HEADER TRANSFERASE 02-MAR-06 2G8N TITLE STRUCTURE OF HPNMT WITH INHIBITOR 3-HYDROXYMETHYL-7-(N-4- TITLE 2 CHLOROPHENYLAMINOSULFONYL)-THIQ AND ADOHCY COMPND MOL_ID: 1; COMPND 2 MOLECULE: PHENYLETHANOLAMINE N-METHYLTRANSFERASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PNMTASE, NORADRENALINE N-METHYLTRANSFERASE; COMPND 5 EC: 2.1.1.28; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)PLYSS; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PNMT-HIS KEYWDS METHYLTRANSFERASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR N.DRINKWATER,C.L.GEE,J.L.MARTIN REVDAT 4 25-OCT-23 2G8N 1 REMARK SEQADV REVDAT 3 13-JUL-11 2G8N 1 VERSN REVDAT 2 24-FEB-09 2G8N 1 VERSN REVDAT 1 12-SEP-06 2G8N 0 JRNL AUTH G.L.GRUNEWALD,M.R.SEIM,R.C.REGIER,J.L.MARTIN,C.L.GEE, JRNL AUTH 2 N.DRINKWATER,K.R.CRISCIONE JRNL TITL COMPARISON OF THE BINDING OF JRNL TITL 2 3-FLUOROMETHYL-7-SULFONYL-1,2,3,4-TETRAHYDROISOQUINOLINES JRNL TITL 3 WITH THEIR ISOSTERIC SULFONAMIDES TO THE ACTIVE SITE OF JRNL TITL 4 PHENYLETHANOLAMINE N-METHYLTRANSFERASE JRNL REF J.MED.CHEM. V. 49 5424 2006 JRNL REFN ISSN 0022-2623 JRNL PMID 16942016 JRNL DOI 10.1021/JM060466D REMARK 2 REMARK 2 RESOLUTION. 2.15 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.15 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.76 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 2524808.750 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 47132 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.201 REMARK 3 FREE R VALUE : 0.243 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.100 REMARK 3 FREE R VALUE TEST SET COUNT : 4737 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.15 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.28 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 6922 REMARK 3 BIN R VALUE (WORKING SET) : 0.2780 REMARK 3 BIN FREE R VALUE : 0.3130 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.90 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 761 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.011 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4106 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 98 REMARK 3 SOLVENT ATOMS : 293 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 51.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 5.44000 REMARK 3 B22 (A**2) : 5.44000 REMARK 3 B33 (A**2) : -10.87000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.26 REMARK 3 ESD FROM SIGMAA (A) : 0.27 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.32 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.33 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.80 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.000 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 3.200 ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : 4.190 ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : 4.820 ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : 5.790 ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.34 REMARK 3 BSOL : 64.36 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : 83_MOD.PARAM REMARK 3 PARAMETER FILE 3 : SAH_MOD2.PARAM REMARK 3 PARAMETER FILE 4 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : SAH_MOD.TOP REMARK 3 TOPOLOGY FILE 4 : 83_MOD.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2G8N COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 10-MAR-06. REMARK 100 THE DEPOSITION ID IS D_1000036826. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-MAR-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : HIRES2 REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : CRYSTALCLEAR (MSC/RIGAKU) REMARK 200 DATA SCALING SOFTWARE : D*TREK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 47217 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.150 REMARK 200 RESOLUTION RANGE LOW (A) : 45.780 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 7.760 REMARK 200 R MERGE (I) : 0.04900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.15 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.23 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.69 REMARK 200 R MERGE FOR SHELL (I) : 0.40200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: 1HNN REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 62.68 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG6K, LICL, CACODYLATE, PH 5.8, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 94.44000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 47.16000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 47.16000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 141.66000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 47.16000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 47.16000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 47.22000 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 47.16000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 47.16000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 141.66000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 47.16000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 47.16000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 47.22000 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 94.44000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL UNIT IS A MONOMER REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2540 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19840 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -18.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 GLY A 3 REMARK 465 ALA A 4 REMARK 465 ASP A 5 REMARK 465 ARG A 6 REMARK 465 SER A 7 REMARK 465 PRO A 8 REMARK 465 ASN A 9 REMARK 465 ALA A 10 REMARK 465 GLY A 11 REMARK 465 ALA A 12 REMARK 465 ALA A 13 REMARK 465 PRO A 14 REMARK 465 ASP A 15 REMARK 465 SER A 16 REMARK 465 ALA A 17 REMARK 465 PRO A 18 REMARK 465 GLY A 19 REMARK 465 GLN A 20 REMARK 465 ALA A 21 REMARK 465 ALA A 22 REMARK 465 GLY A 281 REMARK 465 LEU A 282 REMARK 465 GLU A 283 REMARK 465 HIS A 284 REMARK 465 HIS A 285 REMARK 465 HIS A 286 REMARK 465 HIS A 287 REMARK 465 HIS A 288 REMARK 465 HIS A 289 REMARK 465 MET B 1 REMARK 465 SER B 2 REMARK 465 GLY B 3 REMARK 465 ALA B 4 REMARK 465 ASP B 5 REMARK 465 ARG B 6 REMARK 465 SER B 7 REMARK 465 PRO B 8 REMARK 465 ASN B 9 REMARK 465 ALA B 10 REMARK 465 GLY B 11 REMARK 465 ALA B 12 REMARK 465 ALA B 13 REMARK 465 LEU B 282 REMARK 465 GLU B 283 REMARK 465 HIS B 284 REMARK 465 HIS B 285 REMARK 465 HIS B 286 REMARK 465 HIS B 287 REMARK 465 HIS B 288 REMARK 465 HIS B 289 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 101 146.24 -174.26 REMARK 500 ALA A 167 -70.31 -72.29 REMARK 500 SER A 169 142.06 -39.12 REMARK 500 THR A 264 -164.57 -108.40 REMARK 500 ASP A 267 -176.25 -174.32 REMARK 500 CYS B 183 -65.31 -95.14 REMARK 500 ASP B 267 -175.80 -172.41 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE F83 A 2001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE F83 B 2002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SAH A 3001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SAH B 3002 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1HNN RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMNA PNMT COMPLEXED WITH SK&F 29661 AND REMARK 900 ADOHCY (SAH) REMARK 900 RELATED ID: 1NJI RELATED DB: PDB REMARK 900 THE STRUCTURE OF PHENYLETHANOLAMINE N-METHYLTRANSFERASE IN COMPLEX REMARK 900 WITH S-ADENOSYLHOMOCYSTEINE AND THE INHIBITOR LY 134046 REMARK 900 RELATED ID: 1N7J RELATED DB: PDB REMARK 900 THE STRUCTURE OF PHENYLETHANOLAMINE N-METHYLTRANSFERASE IN COMPLEX REMARK 900 WITH S-ADENOSYLHOMOCYSTEINE AND AN IODINATED INHIBITOR REMARK 900 RELATED ID: 1YZ3 RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN PNMT COMPLEXED WITH COFACTOR PRODUCT ADOHCY AND REMARK 900 INHIBITOR SK&F 64139 REMARK 900 RELATED ID: 2AN3 RELATED DB: PDB REMARK 900 STRUCTURE OF PNMT WITH S-ADENOSYL-L-HOMOCYSTEINE AND THE SEMI-RIGID REMARK 900 ANALOGUE ACCEPTOR SUBSTRATE CIS-(1R,2S)-2-AMINO-1-TETRALOL REMARK 900 RELATED ID: 2AN4 RELATED DB: PDB REMARK 900 STRUCTURE OF PNMT COMPLEXED WITH S-ADENOSYL-L-HOMOCYSTEINE AND THE REMARK 900 ACCEPTOR SUBSTRATE OCTOPAMINE DBREF 2G8N A 1 282 UNP P11086 PNMT_HUMAN 1 282 DBREF 2G8N B 1 282 UNP P11086 PNMT_HUMAN 1 282 SEQADV 2G8N GLU A 283 UNP P11086 EXPRESSION TAG SEQADV 2G8N HIS A 284 UNP P11086 EXPRESSION TAG SEQADV 2G8N HIS A 285 UNP P11086 EXPRESSION TAG SEQADV 2G8N HIS A 286 UNP P11086 EXPRESSION TAG SEQADV 2G8N HIS A 287 UNP P11086 EXPRESSION TAG SEQADV 2G8N HIS A 288 UNP P11086 EXPRESSION TAG SEQADV 2G8N HIS A 289 UNP P11086 EXPRESSION TAG SEQADV 2G8N GLU B 283 UNP P11086 EXPRESSION TAG SEQADV 2G8N HIS B 284 UNP P11086 EXPRESSION TAG SEQADV 2G8N HIS B 285 UNP P11086 EXPRESSION TAG SEQADV 2G8N HIS B 286 UNP P11086 EXPRESSION TAG SEQADV 2G8N HIS B 287 UNP P11086 EXPRESSION TAG SEQADV 2G8N HIS B 288 UNP P11086 EXPRESSION TAG SEQADV 2G8N HIS B 289 UNP P11086 EXPRESSION TAG SEQRES 1 A 289 MET SER GLY ALA ASP ARG SER PRO ASN ALA GLY ALA ALA SEQRES 2 A 289 PRO ASP SER ALA PRO GLY GLN ALA ALA VAL ALA SER ALA SEQRES 3 A 289 TYR GLN ARG PHE GLU PRO ARG ALA TYR LEU ARG ASN ASN SEQRES 4 A 289 TYR ALA PRO PRO ARG GLY ASP LEU CYS ASN PRO ASN GLY SEQRES 5 A 289 VAL GLY PRO TRP LYS LEU ARG CYS LEU ALA GLN THR PHE SEQRES 6 A 289 ALA THR GLY GLU VAL SER GLY ARG THR LEU ILE ASP ILE SEQRES 7 A 289 GLY SER GLY PRO THR VAL TYR GLN LEU LEU SER ALA CYS SEQRES 8 A 289 SER HIS PHE GLU ASP ILE THR MET THR ASP PHE LEU GLU SEQRES 9 A 289 VAL ASN ARG GLN GLU LEU GLY ARG TRP LEU GLN GLU GLU SEQRES 10 A 289 PRO GLY ALA PHE ASN TRP SER MET TYR SER GLN HIS ALA SEQRES 11 A 289 CYS LEU ILE GLU GLY LYS GLY GLU CYS TRP GLN ASP LYS SEQRES 12 A 289 GLU ARG GLN LEU ARG ALA ARG VAL LYS ARG VAL LEU PRO SEQRES 13 A 289 ILE ASP VAL HIS GLN PRO GLN PRO LEU GLY ALA GLY SER SEQRES 14 A 289 PRO ALA PRO LEU PRO ALA ASP ALA LEU VAL SER ALA PHE SEQRES 15 A 289 CYS LEU GLU ALA VAL SER PRO ASP LEU ALA SER PHE GLN SEQRES 16 A 289 ARG ALA LEU ASP HIS ILE THR THR LEU LEU ARG PRO GLY SEQRES 17 A 289 GLY HIS LEU LEU LEU ILE GLY ALA LEU GLU GLU SER TRP SEQRES 18 A 289 TYR LEU ALA GLY GLU ALA ARG LEU THR VAL VAL PRO VAL SEQRES 19 A 289 SER GLU GLU GLU VAL ARG GLU ALA LEU VAL ARG SER GLY SEQRES 20 A 289 TYR LYS VAL ARG ASP LEU ARG THR TYR ILE MET PRO ALA SEQRES 21 A 289 HIS LEU GLN THR GLY VAL ASP ASP VAL LYS GLY VAL PHE SEQRES 22 A 289 PHE ALA TRP ALA GLN LYS VAL GLY LEU GLU HIS HIS HIS SEQRES 23 A 289 HIS HIS HIS SEQRES 1 B 289 MET SER GLY ALA ASP ARG SER PRO ASN ALA GLY ALA ALA SEQRES 2 B 289 PRO ASP SER ALA PRO GLY GLN ALA ALA VAL ALA SER ALA SEQRES 3 B 289 TYR GLN ARG PHE GLU PRO ARG ALA TYR LEU ARG ASN ASN SEQRES 4 B 289 TYR ALA PRO PRO ARG GLY ASP LEU CYS ASN PRO ASN GLY SEQRES 5 B 289 VAL GLY PRO TRP LYS LEU ARG CYS LEU ALA GLN THR PHE SEQRES 6 B 289 ALA THR GLY GLU VAL SER GLY ARG THR LEU ILE ASP ILE SEQRES 7 B 289 GLY SER GLY PRO THR VAL TYR GLN LEU LEU SER ALA CYS SEQRES 8 B 289 SER HIS PHE GLU ASP ILE THR MET THR ASP PHE LEU GLU SEQRES 9 B 289 VAL ASN ARG GLN GLU LEU GLY ARG TRP LEU GLN GLU GLU SEQRES 10 B 289 PRO GLY ALA PHE ASN TRP SER MET TYR SER GLN HIS ALA SEQRES 11 B 289 CYS LEU ILE GLU GLY LYS GLY GLU CYS TRP GLN ASP LYS SEQRES 12 B 289 GLU ARG GLN LEU ARG ALA ARG VAL LYS ARG VAL LEU PRO SEQRES 13 B 289 ILE ASP VAL HIS GLN PRO GLN PRO LEU GLY ALA GLY SER SEQRES 14 B 289 PRO ALA PRO LEU PRO ALA ASP ALA LEU VAL SER ALA PHE SEQRES 15 B 289 CYS LEU GLU ALA VAL SER PRO ASP LEU ALA SER PHE GLN SEQRES 16 B 289 ARG ALA LEU ASP HIS ILE THR THR LEU LEU ARG PRO GLY SEQRES 17 B 289 GLY HIS LEU LEU LEU ILE GLY ALA LEU GLU GLU SER TRP SEQRES 18 B 289 TYR LEU ALA GLY GLU ALA ARG LEU THR VAL VAL PRO VAL SEQRES 19 B 289 SER GLU GLU GLU VAL ARG GLU ALA LEU VAL ARG SER GLY SEQRES 20 B 289 TYR LYS VAL ARG ASP LEU ARG THR TYR ILE MET PRO ALA SEQRES 21 B 289 HIS LEU GLN THR GLY VAL ASP ASP VAL LYS GLY VAL PHE SEQRES 22 B 289 PHE ALA TRP ALA GLN LYS VAL GLY LEU GLU HIS HIS HIS SEQRES 23 B 289 HIS HIS HIS HET F83 A2001 23 HET SAH A3001 26 HET F83 B2002 23 HET SAH B3002 26 HETNAM F83 (3R)-N-(4-CHLOROPHENYL)-3-(HYDROXYMETHYL)-1,2,3,4- HETNAM 2 F83 TETRAHYDROISOQUINOLINE-7-SULFONAMIDE HETNAM SAH S-ADENOSYL-L-HOMOCYSTEINE HETSYN F83 3-HYDROXYMETHYL-7-(N-4-CHLOROPHENYLAMINOSULFONYL)-1,2, HETSYN 2 F83 3,4-TETRAHYDROISOQUINOLINE FORMUL 3 F83 2(C16 H17 CL N2 O3 S) FORMUL 4 SAH 2(C14 H20 N6 O5 S) FORMUL 7 HOH *293(H2 O) HELIX 1 1 SER A 25 PHE A 30 5 6 HELIX 2 2 GLU A 31 ALA A 41 1 11 HELIX 3 3 GLY A 52 ALA A 66 1 15 HELIX 4 4 VAL A 84 LEU A 88 5 5 HELIX 5 5 SER A 89 HIS A 93 5 5 HELIX 6 6 LEU A 103 GLN A 115 1 13 HELIX 7 7 TRP A 123 GLY A 135 1 13 HELIX 8 8 CYS A 139 ARG A 150 1 12 HELIX 9 9 CYS A 183 SER A 188 1 6 HELIX 10 10 ASP A 190 THR A 203 1 14 HELIX 11 11 SER A 235 SER A 246 1 12 HELIX 12 12 PRO A 259 GLN A 263 5 5 HELIX 13 13 SER B 16 TYR B 27 1 12 HELIX 14 14 GLN B 28 PHE B 30 5 3 HELIX 15 15 GLU B 31 ALA B 41 1 11 HELIX 16 16 GLY B 52 THR B 67 1 16 HELIX 17 17 VAL B 84 LEU B 88 5 5 HELIX 18 18 SER B 89 HIS B 93 5 5 HELIX 19 19 LEU B 103 GLN B 115 1 13 HELIX 20 20 TRP B 123 GLY B 135 1 13 HELIX 21 21 CYS B 139 ARG B 150 1 12 HELIX 22 22 CYS B 183 SER B 188 1 6 HELIX 23 23 ASP B 190 THR B 203 1 14 HELIX 24 24 SER B 235 GLY B 247 1 13 HELIX 25 25 PRO B 259 GLN B 263 5 5 SHEET 1 A 7 VAL A 151 LEU A 155 0 SHEET 2 A 7 ASP A 96 THR A 100 1 N MET A 99 O ARG A 153 SHEET 3 A 7 THR A 74 ILE A 78 1 N ASP A 77 O THR A 98 SHEET 4 A 7 ALA A 175 ALA A 181 1 O VAL A 179 N ILE A 78 SHEET 5 A 7 LEU A 205 LEU A 217 1 O ILE A 214 N SER A 180 SHEET 6 A 7 GLY A 271 LYS A 279 -1 O ALA A 277 N LEU A 211 SHEET 7 A 7 TYR A 248 ILE A 257 -1 N ASP A 252 O TRP A 276 SHEET 1 B 2 TRP A 221 ALA A 224 0 SHEET 2 B 2 ALA A 227 THR A 230 -1 O LEU A 229 N TYR A 222 SHEET 1 C 7 VAL B 151 PRO B 156 0 SHEET 2 C 7 ASP B 96 ASP B 101 1 N MET B 99 O LEU B 155 SHEET 3 C 7 THR B 74 ILE B 78 1 N ASP B 77 O THR B 98 SHEET 4 C 7 ALA B 175 ALA B 181 1 O VAL B 179 N ILE B 78 SHEET 5 C 7 LEU B 205 LEU B 217 1 O HIS B 210 N LEU B 178 SHEET 6 C 7 GLY B 271 LYS B 279 -1 O ALA B 275 N LEU B 213 SHEET 7 C 7 TYR B 248 ILE B 257 -1 N TYR B 256 O VAL B 272 SHEET 1 D 2 TRP B 221 ALA B 224 0 SHEET 2 D 2 ALA B 227 THR B 230 -1 O ALA B 227 N ALA B 224 SSBOND 1 CYS A 48 CYS B 139 1555 1555 2.06 SSBOND 2 CYS A 139 CYS B 48 1555 1555 2.05 CISPEP 1 PRO A 42 PRO A 43 0 0.16 CISPEP 2 LEU A 173 PRO A 174 0 -0.18 CISPEP 3 PRO B 42 PRO B 43 0 0.10 CISPEP 4 LEU B 173 PRO B 174 0 -0.10 SITE 1 AC1 15 TYR A 35 ASN A 39 TYR A 40 ARG A 44 SITE 2 AC1 15 VAL A 53 GLY A 54 TYR A 85 TYR A 126 SITE 3 AC1 15 PHE A 182 GLU A 219 TYR A 222 MET A 258 SITE 4 AC1 15 ASP A 267 HOH A1010 HOH A1200 SITE 1 AC2 16 TYR B 35 ASN B 39 TYR B 40 ARG B 44 SITE 2 AC2 16 VAL B 53 GLY B 54 LEU B 58 TYR B 126 SITE 3 AC2 16 PHE B 182 ALA B 186 GLU B 219 TYR B 222 SITE 4 AC2 16 MET B 258 ASP B 267 HOH B1014 HOH B1164 SITE 1 AC3 20 TYR A 27 TYR A 35 TYR A 40 GLY A 79 SITE 2 AC3 20 SER A 80 GLY A 81 THR A 83 TYR A 85 SITE 3 AC3 20 ASP A 101 PHE A 102 LEU A 103 ASN A 106 SITE 4 AC3 20 ASP A 158 VAL A 159 HIS A 160 ALA A 181 SITE 5 AC3 20 PHE A 182 CYS A 183 VAL A 187 HOH A1027 SITE 1 AC4 20 TYR B 27 TYR B 35 TYR B 40 GLY B 79 SITE 2 AC4 20 SER B 80 GLY B 81 THR B 83 TYR B 85 SITE 3 AC4 20 ASP B 101 PHE B 102 LEU B 103 ASN B 106 SITE 4 AC4 20 ILE B 157 ASP B 158 VAL B 159 ALA B 181 SITE 5 AC4 20 PHE B 182 CYS B 183 VAL B 187 HOH B1179 CRYST1 94.320 94.320 188.880 90.00 90.00 90.00 P 43 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010602 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010602 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005294 0.00000